An 18-month-old male pygmy goat was submitted to the North Dakota State University Veterinary Diagnostic Laboratory for necropsy. It had a generalized seborrheic skin condition and, during the 2 weeks prior to death, had become listless and had been losing body condition.
cellular vacuolation. Other tissues showed early postmortem changes and were otherwise unremarkable.
Skin tissue was inoculated onto 5% sheep blood agar a and MacConkey agar a plates and brain-heart infusion a (BHI) broth. An additional blood agar plate was incubated 18-24 hr under a microaerophilic atmosphere with 5% CO, at 37 C. After 18-24 hr, subcultures were made from the BHI broth onto blood agar and MacConkey agar plates and incubated 18-24 hr as previously described. Plates were examined after 24 hr of incubation for different bacterial colony types.
Bacterial isolates were tentatively identified as Staphylococcus hyicus on the basis of colonial morphology, pigment, hemolysis of sheep blood, and gram staining, as well as catalase and coagulase reactions.
2 Confirmation of tentative identification was made by using a commercial identification system. b,4 The organism was sensitive to bacitracin, lincomycin, gentamicin, neomycin, penicillin, sulfathiozole, and tetracycline in a disk diffusion antimicrobial susceptibility test.' It was resistant to polymyxin. Mycotic cultures were negative for fungal pathogens.
Staphylococcus hyicus is the etiologic agent of exudative epidermitis in swine.
5 Viral infection has been suggested as a predisposing factor to infection with S. hyicus but has not been definitely associated with the disease. Virus isolation attempts were not made in this study. The skin lesions observed in the goat are similar to those in swine. The non- Figure 1 . Goat skin. Note the hyperkeratosis of epidermis and neutrophilic exudate confined to the stratum corneum with minimal inflammatory change in the dermis. HE stain. 276 specific renal lesions described in this case have been reported 2. in swine with exudative epidermitis.
3,6
A computerized literature search revealed reports of isolation of S. hyicus from cattle, dogs, cats, swine, and poultry 3 ' but not from the skin of goats. Cattle persistently infected with bovine viral diarrhea virus (BVDV) are known to shed large amounts of virus throughout their life.
Sources and manufacturers
5,9 These immune-tolerant animals appear to be more significant sources of virus on a farm than are immunocompetent cattle that undergo acute BVDV infection.
In herds with a high prevalence of BVDV infection/disease, the percentage of persistently infected cattle may be correspondingly higher.
Detection and elimination of persistently infected cattle is an essential component of a BVDV control program in an infected herd. 8 We report here on the apparent improvement in calf viability and overall health of a herd of dairy cattle affected with BVDV following implementation of a control program consisting of booster vaccinations and elimination of immune-tolerant carrier animals. Additionally, we report the results of an attempt to produce mucosal disease in a calf that was found to be an immune-tolerant carrier of BVDV and suggest practical measures for managing BVDV-infected dairy herds.
A Minnesota dairy herd suffered severe neonatal calf losses in 1986 and 1987 due to BVDV infection manifested pri- Presented at the 31st Annual Meeting of the AAVLD, Little Rock, AR, October [15] [16] [17] [18] 1988 .
Received for publication October 19, 1988. marily by neonatal calf diarrhea (Table 1) . Upon sampling the entire herd, virus neutralization (VN) titers of many cows were found to be low. 11 The virus was isolated from buffy coats of blood and from serum samples of several cows and calves. Two booster vaccinations were administered at a 3-week interval using a killed BVDV vaccine. The herd was re-bled 21 days after the last vaccination and several calves were found to be immune-tolerant carriers of noncytopathic BVDV as determined by virus isolation from their buffy coats and by low VN titers (1:2 and 1:4) after booster vaccinations. After the removal of immune-tolerant carriers and the administration of booster vaccinations, calf viability and milk production improved greatly in the herd (Table 1) . The newborn calves were larger and more vigorous at birth and fewer repeat breeders were reported. Currently, the animals in the herd are given booster vaccinations with a killed bovine viral diarrhea (BVD) vaccine once every year in the spring; calves receive 2 immunizations 3 weeks apart starting at approximately 4 months of age.
A 6-month-old Holstein calf Y24) from this herd was donated to the College of Veterinary Medicine, University of Minnesota. The calf had been removed from the herd because of persistent isolation of BVDV from buffy coat samples and because it maintained a low VN titer (1:2 to 1:4) to BVDV. The calf was thin and small for its age and weighed 79.5 kg. An attempt was made to produce mucosal disease in this calf by inoculating it with 2 different strains of cytopathic BVDV given 7 weeks apart. The animal was monitored prior to, during, and after virus inoculation for clinical signs, virus shedding, antibody titers, and neutrophil counts. Virus isolation was attempted on heparinized blood, saliva, tears, urine, and feces to document viral shedding. The calf was inoculated intravenously with cytopathic BVDV
